Amarin Corp Plcuk (AMRN) Net Cash Flow (2010 - 2026)
Amarin Corp Plc\Uk (AMRN) posted quarterly Net Cash Flow of $12.5 million for Q2 2026, down 55.93% year-over-year from $28.4 million in Q2 2025, and up 447.37% quarter-over-quarter from -$3.6 million in Q1 2026.
Amarin Corp Plcuk (AMRN) Net Cash Flow (2010 - 2026) Analysis & Trends
Amarin Corp Plc\Uk (AMRN) has reported Net Cash Flow for 17 consecutive years, with $12.5 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Net Cash Flow fell 55.93% year-over-year to $12.5 million; the TTM figure through Jun 2026 stood at -$4.4 million (up 93.53% YoY), while the FY2025 annual figure was $13.5 million, up 117.24% from the prior year.
- Net Cash Flow climbed to $12.5 million in Q2 2026 per AMRN's latest filing, from -$3.6 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $41.6 million in Q2 2023 and bottomed at -$71.6 million in Q4 2023.
- Historically, Net Cash Flow has averaged -$4.4 million across 5 years, with a median of $838500.0 in 2022.
- Annual changes were most pronounced in 2023 — Net Cash Flow sank 8564.69% — and 2025, when it soared 1331.97%.
- Amarin Corp Plc\Uk's Net Cash Flow stood at -$26.2 million in 2022, then slumped by 172.83% to -$71.6 million in 2023, then soared by 49.51% to -$36.1 million in 2024, then soared by 132.54% to $11.8 million in 2025, then grew by 6.27% to $12.5 million in 2026.
- Business Quant data shows AMRN's Net Cash Flow at $12.5 million in Q2 2026, -$3.6 million in Q1 2026, and $11.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.77 Bn | 632.01 Bn | 17.26 Bn | -1.27 Bn |
| 2 | AbbVie | 469.90 Bn | 463.33 Bn | 12.70 Bn | -2.82 Bn |
| 3 | Merck | 377.04 Bn | 369.90 Bn | 12.21 Bn | 1.53 Bn |
| 4 | Novartis Ag | 303.08 Bn | 295.39 Bn | 11.24 Bn | 757.00 Mn |
| 5 | Astrazeneca | 257.74 Bn | 252.84 Bn | 12.86 Bn | -6.80 Bn |
| 6 | Amgen | 236.46 Bn | 222.47 Bn | 7.24 Bn | 1.95 Bn |
| 7 | Gilead Sciences | 181.81 Bn | 178.63 Bn | 6.22 Bn | -4.43 Bn |
| 8 | Pfizer | 159.20 Bn | 147.50 Bn | 10.94 Bn | -722.00 Mn |
| 9 | Gsk | 106.28 Bn | 102.11 Bn | 8.24 Bn | 2.68 Bn |
| 10 | Amarin Corp Plcuk | 5.87 Bn | 5.56 Bn | 14.99 Mn | 12.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.50 Mn |
| Jun 30, 2026 | 12.50 Mn |
| Mar 31, 2026 | -3.60 Mn |
| Mar 31, 2026 | -3.60 Mn |
| Dec 31, 2025 | 11.76 Mn |
| Dec 31, 2025 | 11.76 Mn |
| Sep 30, 2025 | -25.07 Mn |
| Sep 30, 2025 | -25.07 Mn |
| Jun 30, 2025 | 28.35 Mn |
| Jun 30, 2025 | 28.35 Mn |
| Mar 31, 2025 | -1.51 Mn |
| Mar 31, 2025 | -1.51 Mn |
| Dec 31, 2024 | -36.13 Mn |
| Dec 31, 2024 | -36.13 Mn |
| Sep 30, 2024 | -58.98 Mn |
| Sep 30, 2024 | -58.98 Mn |
| Jun 30, 2024 | 1.98 Mn |
| Jun 30, 2024 | 1.98 Mn |
| Mar 31, 2024 | 14.69 Mn |
| Mar 31, 2024 | 14.69 Mn |